BSX Boston Scientific Corporation
Boston Scientific Corporation (BSX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 25, 2026 , by Morano Susan E .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Morano Susan E | Director | Buy | 2,040 | $49.22 | $100.4K | 13,784 | |
| Habiger David C | Director | Buy | 2,100 | $47.59 | $99.9K | 17,160 | |
| Habiger David C | Director | Buy | 140 | $48.59 | $6.8K | 15,060 | |
| Mahoney Michael F | Chairman, President & CEO | Buy | 186,240 | $48.33 | $9.0M | 1,590,024 | |
| Habiger David C | Director | Buy | 1,042 | $48.07 | $50.1K | 14,920 | |
| LUDWIG EDWARD J | Director | Buy | 5,000 | $45.48 | $227.4K | 30,359 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.